Tenet Healthcare Appoints Senator Roy Blunt to Board of Directors
10 Agosto 2023 - 5:05PM
Business Wire
Tenet Healthcare Corporation (NYSE: THC) today announced the
appointment of Senator Roy Blunt to the Tenet Board of Directors,
effective immediately. Senator Blunt will serve as a member of the
Audit Committee, Nominating and Corporate Governance Committee, and
Environmental, Social, and Governance Committee. This appointment
expands the Board to 12 directors, 11 of whom are independent
members.
“We are pleased to welcome Senator Roy Blunt as a new board
member,” said Saum Sutaria, M.D., Chief Executive Officer of Tenet.
“With more than 25 years of legislative experience, Roy’s expertise
in public policy and addressing cross-cutting issues will be
invaluable to helping Tenet make a lasting, positive impact on the
communities we serve while also increasing long-term value for our
shareholders.”
Senator Blunt is currently the Chairman of the Leadership
Advisory Strategies group at Husch Blackwell Strategies. Senator
Blunt was elected to the U.S. House of Representatives in 1996 and
U.S. Senate in 2010, consistently demonstrating his commitment to
serving the public with unwavering integrity and purpose.
Throughout his career, Senator Blunt has spearheaded major
legislative achievements in health care and other highly regulated
industries, with a commitment to medical research and
discovery.
Senator Blunt served on committees in Congress where his
leadership helped shape key policies. This includes service as
Chairman of the Senate Rules Committee as well as serving on the
Senate Appropriations Committee, Senate Commerce, Science and
Transportation Committee, and the Senate Select Committee on
Intelligence. Notably, Senator Blunt was Chairman of the
Appropriations Subcommittee on Labor, Health and Human Services,
and Education, underscoring his focus on health care and health
research. During his eight years on the subcommittee, Senator Blunt
focused resources and awareness on critical issues including
increasing funding for medical research centers and Alzheimer’s
disease research.
Prior to his tenure in Congress, he was a history teacher,
county official, and Missouri’s Secretary of State. Senator Blunt
also served four years as the president of Southwest Baptist
University. Senator Blunt is actively involved in promoting and
preserving the arts and history. He has served as a member of the
Smithsonian Council for American Art, as President of the State
Historical Society of Missouri, and as a member of the Kennedy
Center Board of Trustees.
Senator Blunt is an Executive Fellow at the Bipartisan Policy
Center in Washington, D. C. He also chairs the Advisory Board of
the National Geospatial Agency of the U. S. Government and serves
on the Southwest Airlines Board of Directors.
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified
healthcare services company headquartered in Dallas. Our care
delivery network includes United Surgical Partners International,
the largest ambulatory platform in the country, which operates or
has ownership interests in more than 475 ambulatory surgery centers
and surgical hospitals. We also operate 61 acute care and specialty
hospitals, approximately 110 other outpatient facilities, a network
of leading employed physicians and a global business center in
Manila, Philippines. Our Conifer Health Solutions subsidiary
provides revenue cycle management and value-based care services to
hospitals, health systems, physician practices, employers, and
other clients. Across the Tenet enterprise, we are united by our
mission to deliver quality, compassionate care in the communities
we serve. For more information, please visit
www.tenethealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230809741212/en/
Investor Contact Will McDowell 469-893-2387
William.McDowell@tenethealth.com
Media Contact Robert Dyer 469-893-2640
mediarelations@tenethealth.com
Tenet Healthcare (NYSE:THC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Tenet Healthcare (NYSE:THC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024